Fascia Iliaca Compartment Block for Proximal-end Femur Fractures
NCT ID: NCT02696915
Last Updated: 2016-03-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
60 participants
INTERVENTIONAL
2015-01-31
2015-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Fascia iliaca compartment block is highly effective in blocking lateral cutaneous nerve of the thigh and femoral nerve. Fascia iliaca compartment block is not only easy to perform but it is also associated with minimal risk as the local anesthetic is injected at a safe distance from the femoral artery and femoral nerve. It is always safe to perform the fascia iliaca compartment block prior to spinal anesthesia as the patient can respond during administration of the local anesthetic and can prevent intra-neuronal injections
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Fascia Iliaca Block Versus Intravenous Dexmedetomidine and Ketamine for Positioning Fracture Femur
NCT05705726
Peri-Capsular Nerve Group and Supra Inguinal Fascia Iliaca BLOCK for Analgesia and Ease of Positioning During Neuraxial Anesthesia in Hip Fracture Patients
NCT05987254
Fascia Iliaca Compartment Block Versus Anterior Quadratus Lumborum Block
NCT04709211
Dexmedetomidine Addition to Fascia Iliaca Compartment Block
NCT01600027
Ultrasound-Guided Fascia Iliaca Compartmental Block Versus Spinal Anesthesia in Femoral Thrombectomy
NCT06745986
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
On arrival to the operative theater, under complete aseptic technique spinal anesthesia will be carried out in the sitting position (if there is severe pain at positioning we will use lateral position) at space between L3-4 or L4-5 using a 25-gauge spinal quincke needle. After feeling the desired space, the needle will be advanced (paramedian approach) till free flow of cerebrospinal fluid dropped from the needle then 15 mg hyperbaric bupivacaine+20mic fentanyl will be injected.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Placebo
Patients received ultrasound guided fascia iliaca compartment block using 40 ml of saline 0.9%. Then intrathecal medications will be administered.
Placebo
Patients received ultrasound guided fascial iliaca compartment blockade using normal saline 0.9%, 40 ml
Ultrasound guided fascia iliaca compartment block
Ultrasound guided fascia iliaca compartment block
Intrathecal medications (bupivacaine (15 mg) in conjunction with fentanyl 20 micrograms)
Intrathecal hyperbaric bupivacaine (15 mg) in conjunction with fentanyl 20 micrograms
Bupivacaine
Patients received ultrasound guided fascia iliaca compartment block using 40 ml of 0.25% bupivacaine. Then intrathecal medications will be administered.
Bupivacaine
Patients received ultrasound guided fascial iliaca compartment blockade using bupivacaine 0.25%, 40 ml
Ultrasound guided fascia iliaca compartment block
Ultrasound guided fascia iliaca compartment block
Intrathecal medications (bupivacaine (15 mg) in conjunction with fentanyl 20 micrograms)
Intrathecal hyperbaric bupivacaine (15 mg) in conjunction with fentanyl 20 micrograms
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Placebo
Patients received ultrasound guided fascial iliaca compartment blockade using normal saline 0.9%, 40 ml
Bupivacaine
Patients received ultrasound guided fascial iliaca compartment blockade using bupivacaine 0.25%, 40 ml
Ultrasound guided fascia iliaca compartment block
Ultrasound guided fascia iliaca compartment block
Intrathecal medications (bupivacaine (15 mg) in conjunction with fentanyl 20 micrograms)
Intrathecal hyperbaric bupivacaine (15 mg) in conjunction with fentanyl 20 micrograms
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients scheduled for fixation for proximal end femur fracture
Exclusion Criteria
* Morbid obese patients (BMI\>40)
* Bleeding diathesis
* Previous femoral bypass surgery
* Inguinal hernia
* Inflammation/infection over injection site
* Peripheral neuropathy
* Allergy to local anesthetics agents used.
* Severely altered consciousness level
* Psychiatric disorders
* Polytrauma
20 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mansoura University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Reem A El Sharkawy, MD
Role: STUDY_CHAIR
Lecturer of Anesthesia and Surgical Intensive Care
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mansoura University Hospitals
Al Mansurah, DK, Egypt
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Guay J, Kopp S. Peripheral nerve blocks for hip fractures in adults. Cochrane Database Syst Rev. 2020 Nov 25;11(11):CD001159. doi: 10.1002/14651858.CD001159.pub3.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MS/811
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.